JPMorgan analyst Brian Essex adjusted the price target for IBM (NYSE:IBM) shares to $244, up from the previous $233, while ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

J.P. Morgan analyst Sandeep Deshpande maintained a Hold rating on Telefonaktiebolaget LM Ericsson Class B (0O87 – Research Report) today and ...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to ...

How JPMorgan Chase performs in 2025 will largely depend on how economic conditions evolve. A backdrop of a firm labor market ...

Fintel reports that on January 28, 2025, JP Morgan upgraded their outlook for Ciena (NYSE:CIEN) from Neutral to Overweight.

Vishal Mega Mart's growth strategy looks more defendable than peers' given its scale, according to Morgan Stanley. The risks ...

JPMorgan Chase & Co. filed an 8-K report with the Securities and Exchange Commission, informing shareholders about the ...

After losing $589B in market cap on Monday, shares of Nvidia (NVDA) climbed about 4% premarket on Tuesday, showing signs of ...

JP Morgan analyst Matthew Boss reiterated an Overweight rating on the shares of Viking Holdings Ltd (NYSE:VIK) and raised the ...